Suppr超能文献

在密码子优化的严重急性呼吸综合征相关冠状病毒刺突蛋白中鉴定小鼠CD8 T细胞表位

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.

作者信息

Zhi Yan, Kobinger Gary P, Jordan Heather, Suchma Katie, Weiss Susan R, Shen Hao, Schumer Gregory, Gao Guangping, Boyer Julie L, Crystal Ronald G, Wilson James M

机构信息

Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104, USA.

出版信息

Virology. 2005 Apr 25;335(1):34-45. doi: 10.1016/j.virol.2005.01.050.

Abstract

The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.

摘要

严重急性呼吸综合征(SARS)的病原体已被确定为一种新型冠状病毒,即SARS相关冠状病毒(SARS-CoV)。CD8 T细胞在控制由其他冠状病毒引起的疾病以及在相应动物模型中介导疫苗诱导的保护性免疫方面发挥着重要作用。刺突蛋白是SARS-CoV的主要表面抗原,是疫苗设计中最重要的抗原候选物之一。使用重叠肽来鉴定在用编码密码子优化的SARS-CoV刺突蛋白的载体免疫的小鼠中主要组织相容性复合体I类限制性表位。CD8 T细胞反应被定位到两个H-2(b)限制性表位(S436-443和S525-532)和一个H-2(d)限制性表位(S366-374)。这些表位的鉴定将有助于在SARS-CoV感染的小鼠模型中评估疫苗策略。此外,密码子和启动子优化可以在复制缺陷型人类和猿猴腺病毒疫苗载体的背景下大大增强刺突蛋白的整体免疫原性。编码刺突的优化重组腺病毒疫苗载体可以在小鼠中产生强大的抗原特异性细胞免疫,并且可能对控制SARS-CoV感染有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4c/7111773/4efa904c98cd/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验